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Abstract
AIM
To investigate whether the adipocytes derived hormone 
adiponectin (ADPN) affects the mechanical responses in 
strips from the mouse gastric fundus. 
METHODS
For functional experiments, gastric strips from the fundal 
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region were cut in the direction of the longitudinal mus-
cle layer and placed in organ baths containing Krebs-
Henseleit solution. Mechanical responses were recorded via 
force-displacement transducers, which were coupled to a 
polygraph for continuous recording of isometric tension. 
Electrical field stimulation (EFS) was applied via  two 
platinum wire rings through which the preparation was 
threaded. The effects of ADPN were investigated on the 
neurally-induced contractile and relaxant responses elicited 
by EFS. The expression of ADPN receptors, Adipo-R1 and 
Adipo-R2, was also evaluated by touchdown-PCR analysis. 
RESULTS
In the functional experiments, EFS (4-16 Hz) elicited 
tetrodotoxin (TTX)-sensitive contractile responses. Ad-
dition of ADPN to the bath medium caused a reduction in 
amplitude of the neurally-induced contractile responses 
(P  < 0.05). The effects of ADPN were no longer observed 
in the presence of the nitric oxide (NO) synthesis inhibitor 
L-NG-nitro arginine (L-NNA) (P  > 0.05). The direct smooth 
muscle response to methacholine was not influenced by 
ADPN (P  > 0.05). In carbachol precontracted strips and 
in the presence of guanethidine, EFS induced relaxant 
responses. Addition of ADPN to the bath medium, other 
than causing a slight and progressive decay of the basal 
tension, increased the amplitude of the neurally-induced 
relaxant responses (P  < 0.05). Touchdown-PCR analysis 
revealed the expression of both Adipo-R1 and Adipo-R2 in 
the gastric fundus.
CONCLUSION
The results indicate for the first time that ADPN is able 
to influence the mechanical responses in strips from the 
mouse gastric fundus. 
Key words: Adiponectin; Adiponectin receptors; Gastric 
motility; Nitric oxide; Non-adrenergic, non-cholinergic 
neurotransmission 
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Evidence exists that some white adipose-tissue 
derived hormones that are involved in the regulation of 
food intake also influence the motor responses of the 
gastrointestinal tract. In this view, adiponectin (ADPN) too 
has been reported to influence food intake but no data 
concerning its effects on the gastric mechanical activity 
are available. The present results indicate for the first time 
that ADPN is able to influence the mechanical responses 
in strips from the mouse gastric fundus. It could be 
speculated that these peripheral effects on motor pheno-
mena might represent an additional mechanism engaged 
by the hormone to control food intake.  
Idrizaj E, Garella R, Castellini G, Mohr H, Pellegata NS, Francini 
F, Ricca V, Squecco R, Baccari MC. Adiponectin affects the 
mechanical responses in strips from the mouse gastric fundus. 
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INTRODUCTION
White adipose tissue is recognized as an endocrine or­
gan[1], being able to secrete many substances, known 
as adipokines, that are involved in a wide range of 
functions[1,2]. Among them, accumulating evidence 
suggests that adipose­tissue derived hormones, such 
as leptin and adiponectin (ADPN), play an important 
role in the systemic metabolic homeostasis, also acting 
as key neuromodulators of food intake[1­6]. ADPN is a 
peptide hormone mainly produced by white adipose 
tissue although its expression has been reported also 
in other organs of different animal species[7], including 
the mouse stomach[8]. ADPN exerts its effects mainly 
through the activation of two seven transmembrane 
domain receptors, Adipo­R1 and Adipo­R2[9], whose 
expression has been revealed, other than in the brain, in 
a variety of mammalian peripheral tissues[7]. Particularly, 
Adipo­R2 mRNA expression has been reported in the 
gastrointestinal tract of rats[10].
Interestingly, many substances that act centrally 
to modulate food intake also influence the activity of 
gastrointestinal smooth muscle[11­14], whose motor phe­
nomena represent a source of peripheral signals involved 
in the control of feeding behavior thought the gut­brain 
axis[15].
All the above knowledge are consistent with the 
possibility that ADPN too could affect gastrointestinal 
motor responses, although no data are present in the 
literature concerning these effects.
On this ground, in the present study we investigated 
whether ADPN influences the mechanical responses in 
strips from the mouse gastric fundus. The expression 
of both the ADPN receptors was also evaluated by 
touchdown­PCR analysis. 
MATERIALS AND METHODS
Animals
Experiments were carried out on 8­12 wk old C57BL/6 
female mice (Charles River, Lecco, Italy). The animals 
were fed standard laboratory chow and water, and were 
housed under a 12­h light/12­h dark (12 L : 12 D) 
photoperiod and controlled temperature (21 ℃± 1 ℃). 
The experimental protocol was designed in compliance 
with the guidelines of the European Communities Council 
Directive 2010/63/UE and the recommendations for 
the care and use of laboratory animals approved by the 
Animal Care Committee of the University of Florence, 
Italy, with authorization from the Italian Ministry of 
Health nr. 787/2016­PR. The mice were killed by prompt 
cervical dislocation to minimize animal suffering. 
Mechanical experiments
As previously published by our research group[16,17], the 
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stomach was rapidly dissected from the abdomen and 
two full­thickness strips (2 mm × 10 mm) were cut 
in the direction of the longitudinal muscle layer from 
each fundal region. One end of each strip was tied to a 
platinum rod while the other was connected to a force 
displacement transducer (Grass model FT03) by a silk 
thread for continuous recording of isometric tension. 
The transducer was coupled to a polygraph (7K; Grass 
Instrument). Muscle strips were mounted in 5 mL double­
jacketed organ baths containing Krebs­Henseleit solution, 
which consisted of 118 mmol/L NaCl, 4.7 mmol/L KCl, 
1.2 mmol/L MgSO4, 1.2 mmol/L KH2PO4, 25 mmol/L 
NaHCO3, 2.5 mmol/L CaCl2, and 10 mmol/L glucose pH 
7.4, and bubbled with 95% O2/5% CO2. Prewarmed 
water (37 ℃) was circulated through the outer jacket 
of the tissue bath via a constant­temperature circulator 
pump. The temperature of the Krebs­Henseleit solution 
in the organ bath was maintained within ± 0.5 ℃.
Electrical field stimulation (EFS) was applied via 
two platinum wire rings (2 mm diameter, 5 mm apart) 
through which the preparation was threaded. Electrical 
impulses (rectangular waves, 80 V, 4­16 Hz, 0.5 ms, for 
15 s) were provided by a Grass model S8 stimulator. 
Strips were allowed to equilibrate for 1 h under an initial 
load of 0.8 g. During this period, repeated and prolonged 
washes of the preparations with Krebs­Henseleit solution 
were done to avoid accumulation of metabolites in the 
organ baths.
Drugs 
The following drugs were used: acetyl­β­methylcholine 
chloride (methacholine), recombinant full­length mouse 
adiponectin (ADPN), atropine sulphate, carbachol (CCh), 
guanethidine sulphate, L­NG­nitro arginine (L­NNA), 
tetrodotoxin (TTX). All drugs were obtained from Sigma 
Chemical (St. Louis, MO, United States). Solutions were 
prepared on the day of the experiment, except for TTX 
and ADPN, for which stock solutions were kept stored at 
­20 ℃.
Drug concentrations are referred as final bath con­
centrations. For ADPN we started from 20 pmol/L, i.e., 
the dose previously reported to be effective in in vitro 
gastric preparations[8]. Direct smooth muscle contractions 
were obtained by addition of methacholine to the 
bath medium. The interval between two subsequent 
applications of methacholine was no less than 30 
min, during which repeated and prolonged washes of 
the preparations with Krebs­Henseleit solution were 
performed. In order to investigate the effects of ADPN 
in non­adrenergic, non­cholinergic (NANC) condition, 
guanethidine and CCh were added to the bath medium, 
to rule out the adrenergic and the cholinergic influences, 
respectively. When contraction elicited by CCh reached a 
stable plateau phase, EFS or drugs were applied.   
Polymerase chain reaction for ADPN receptors
Aiming to assess the presence of mRNA for ADPN recep­
tors in gastric fundal tissue, mouse tissues were snap­
frozen in liquid nitrogen and stored at ­80 ℃ until use.
Then, from frozen tissue sections, RNA was extracted 
using RNeasy Mini Kit (Qiagen, Hilden, Germany) fol­
lowing the manufacturer’s instructions. Polymerase chain 
reaction (PCR) was performed for AdipoR1 and AdipoR2 
receptors and the following primers were used: 
AdipoR1 forward 5’­CAG AGA AGC TGA CAC AGT 
GGA G­3’ and reverse 5’­GTC CCT CCC AGA CCT TAT 
ACA C­3’; AdipoR2 forward 5’­GGA CTC CAG AGC CAG 
ATA TAC G­3’ and reverse 5’­ACT CTT CCA TTC GTT CCA 
TAG C­3’. 
The mixtures listed in Table 1 were prepared in thin 
walled 0.2 mL tubes and analysed by Biometra PCR 
cycler. PCRs were run with the program reported in Table 
2.
Three gastric fundus were evaluated and a negative 
control without cDNA template as well as a positive 
control containing cDNA of inguinal fat pad were ana­
lyzed in parallel. The positive control was chosen since 
both Adipo­R1 and Adipo­R2 are well expressed in 
adipocytes which are the most relevant cell types for 
these receptors[18].
Data collection 
Amplitude of contractile responses is expressed as 
percentage of the muscular contraction evoked by 2 
μmol/L methacholine, assumed as 100% or as abso­
lute values (g). Amplitude of contractile responses 
to methacholine was measured 30 s after a stable 
plateau phase was reached. Relaxant responses are 
expressed as percentage decrease relative to the 
muscular tension induced by 1 μmol/L CCh just before 
obtaining relaxations. Amplitude values of EFS­induced 
relaxations refer to the maximal peak obtained during 
the stimulation period.  
Statistical analysis
Statistical analysis was performed by means of 
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Reagents Volume
Forward primer (0.01 pmol/L) 1 μL
Reverse primer (0.01 pmol/L) 1 μL
GOTaq colorless Master Mix sample (PromegaR) 12.5 μL
H2O    9.5 μL
cDNA template 1 μL
Table 1  PCR components
Step Temperature (℃) Time Note
1 94 3 min -
2 94 20 s -
3 64 30 s -0.5 ℃ per cycle
4 72 35 s Repeat steps 2-4 for 12 cycles
5 94 20 s -
6 58 30 s -
7 72 35 s Repeat steps 5-7 for 25 cycles
8 72 2 min -
9 4 Hold
Table 2  Touchdown-PCR setup
Idrizaj E et al . Effects of adiponectin on gastric strips
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responses in the whole range of stimulation frequency 
employed (Figure 1A and B). The effects of ADPN were 
already appreciable 10 min after its addition to the bath 
medium and persisted up to 60 min (longer time not 
observed). Addition of the nitric oxide (NO) synthesis 
inhibitor L­NNA (200 μmol/L) to the bath medium (n = 
6) caused an increase in amplitude of the EFS­induced 
contractile responses (Figure 1B). In the presence of 
L­NNA, the depressant effects of ADPN on the neurally­
induced contractile responses were no longer observed 
(Figure 1B). 
Addition of the muscarinic receptors agonist metha­
choline (2 μmol/L) to the bath medium (n = 4) caused, 
after 10­15 s of contact time, a sustained contracture 
which reached a plateau phase (mean amplitude 0.99 g 
± 0.2 g) that persisted until washout. The amplitude of 
the direct muscular response elicited by methacholine 
was not influenced by 20 nmol/L ADPN (mean amplitude 
0.98 ± 0.3; P > 0.05).  
The effects of ADPN on the fundal strips were also 
tested in NANC conditions. As previously observed[16], 
Student’s t­test to compare two experimental groups 
or one­way ANOVA followed by Newman­Keuls posttest 
when more than two groups were compared. Values 
were considered significantly different with P < 0.05. 
Results are given as means ± SE. The number of muscle 
strip preparations is designated by n in the results.
RESULTS
Mechanical experiments
At basal tension EFS (4­16 Hz) induced (n = 22) con­
tractile responses, whose amplitude increased by in­
creasing the stimulation frequency (Figure 1A). As pre­
viously observed in the mouse gastric fundus[16,17], the 
EFS­evoked contractile responses were abolished by TTX 
(1 μmol/L) (P < 0.05) or atropine (1 μmol/L) (P < 0.05), 
thus indicating that they were neurally­induced and 
cholinergic in nature.
Addition of ADPN to the bath medium caused, at 20 
nmol/L (n = 12), a statistically significant reduction (P 
< 0.05) in amplitude of the neurally­induced excitatory 
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Figure 1  Effects of adiponectin on the neurally-induced contractile responses in strips from the mouse gastric fundus. A: Typical tracing showing the 
contractile responses to EFS (left hand panel). ADPN (20 nmol/L) decreases the amplitude of the neurally-induced contractile responses (right hand panel); B: Bar 
charts showing the influence of ADPN (20 nmol/L) on the mean amplitude of the EFS-induced contractile responses in the absence (left hand panel) and in the 
presence (right hand panel) of L-NNA (200 μmol/L). Note that, in the presence of L-NNA, ADPN no longer decreases the amplitude of the neurally-induced excitatory 
responses in the whole range of stimulation frequency employed. Amplitude of contractile responses is expressed as percentage of the muscular contraction evoked 
by 2 μmol/L methacholine, assumed as 100%. All values are means ± SE of 6 strips from 3 mice. aP < 0.05 vs the control; bP < 0.05 and P > 0.05 vs the control and 
vs L-NNA, respectively (Student's t-test plus ANOVA and Newman-Keuls post-test). ADPN: Adiponectin; L-NNA: L-NG-nitro arginine.
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CCh (1 μmol/L) induced (n = 18) a contractile response 
(mean amplitude 1.1 g ± 0.3 g) that reached a plateau 
phase which persisted until washout. Addition of ADPN 
(20 nmol/L) to the bath medium caused, in 14 out of the 
18 strips examined, a slight (mean amplitude 0.15 g ± 
0.02 g) and progressive decay of the basal tension that 
was not influenced by 1 μmol/L TTX (P > 0.05). In CCh 
precontracted strips, EFS (4­16 Hz) elicited (n = 16), 
during the stimulation period, relaxant responses (Figure 
2A) whose amplitudes were increased following the 
addition of ADPN (20 nmol/L) to the bath medium (Figure 
2A and B). 
Touchdown-PCR analysis 
By touchdown­PCR analysis ADPN receptors expression, 
analysed using specific primer pairs for Adipo­R1 and 
Adipo­R2, has been detected in cDNA in three murine 
gastric fundus. Two bands corresponding to Adipo­R1 and 
Adipo-R2 were identified in agarose gel electrophoresis. 
The positive controls were derived from inguinal fat pad 
cDNA. A typical experiment from a gastric fundus is 
shown in Figure 3. 
DISCUSSION
The results of the present study indicate for the first 
time that ADPN is able to influence the motor responses 
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Figure 2  Effects of adiponectin on the neurally-induced relaxant responses in strips from the mouse gastric fundus. A: Typical tracing showing the relaxant 
responses to EFS (left hand panel). ADPN (20 nmol/L) increases the amplitude of the neurally-induced relaxant responses (right hand panel); B: Bar chart showing 
the influence of ADPN on the mean amplitude of the EFS-induced relaxant responses. Note that ADPN increases the amplitude of the neurally-induced relaxation in 
the whole range of stimulation frequency employed. Relaxant responses are expressed as percentage decrease relative to the muscular tension induced by 1 μmol/L 
CCh just before obtaining relaxations. All values are means ± SE of 6 strips from 3 mice. aP < 0.05 vs the control (Student's t-test). ADPN: Adiponectin.
Figure 3  Expression of adiponectin receptors, Adipo-R1 and Adipo-R2, 
in murine gastric fundus. Typical PCR analysis recorded in the same GF 
revealed the expression of both AdipoR1 (left hand) and AdipoR2 (right hand) 
receptors. Positive controls derived from inguinal fat pad cDNA (Fat) and NC 
without cDNA template (water). Marker: 100 bp marker (NEB). GF: Gastric 
fundus; NC: Negative control.
300 bp
200 bp
100 bp
Marker     GF        Fat       NC         GF         Fat         NC
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in strips from the mouse gastric fundus in which we re­
vealed the expression of both Adipo­R1 and Adipo­R2. 
Particularly, the ability of ADPN to reduce the amplitude 
of the neurally­induced contractile responses, without 
affecting the direct muscular response to methacholine, 
indicates that the hormone exerts a neuromodulatory 
action. Furthermore, the lack of effects of ADPN on 
the contraction to methacholine, other than excluding 
non­specific effects, demonstrated that muscle re­
sponsiveness was not compromised.
It is known that gastric motor responses are the result 
of a balance between nervous excitatory and inhibitory 
influences on the smooth muscle and that during EFS 
both excitatory cholinergic and NANC inhibitory nervous 
fibres are activated. Thus, the reduction in amplitude 
of the neurally­induced contractile responses by ADPN, 
observed in the present experiments, may be ascribable 
to either a minor activation of the excitatory component 
or to a major nervous inhibitory influence exerted on 
the smooth muscle. In this view, NO is considered 
the main NANC inhibitory neurotransmitter released 
during EFS to cause gastrointestinal relaxation[19,20]. 
Actually, the increase in amplitude of the EFS­induced 
contractile responses by the NO synthesis inhibitor L­NNA 
supports the removal of a nitrergic inhibitory nervous 
influence. Notably, the observation that ADPN, in the 
presence of L­NNA, is no longer able to depress the 
amplitude of the neurally­induced excitatory responses 
strongly indicates that the nitrergic neurotransmission is 
involved in the depressant effects of the hormone. This 
is further confirmed by the ability of ADPN to increase 
the amplitude of the EFS­induced relaxant responses 
(elicited by EFS during the stimulation period) whose 
nitrergic nature has been reported in the mouse gastric 
fundus[16,21]. Actually, NO appears to be a shared target 
pathway in the hormonal control of gastrointestinal 
motility[16,21­24] and thus ADPN effects too may occur, at 
least in part, through NO. In this view, the ability of the 
hormone to increase NO synthase expression has been 
reported in vascular tissues[25,26].
However, in the present study, the observation that 
ADPN is also able to cause a TTX­insensitive decay of 
the basal tension indicates that the hormone, in addition 
to its neuromodulatory effects, exerts a direct muscular 
action. Experiments are in progress to better clarify these 
direct effects of ADPN on gastric smooth muscle. 
From a physiological point of view, the ability of 
ADPN to decrease the amplitude of the neurally­induced 
contractile responses and to enhance that of the relaxant 
ones, coupled to a decay of the basal tension, suggests 
that the hormone effects are directed to facilitate gastric 
relaxation, so increasing the distension of the gastric 
wall and in turn the organ capacity. Thus, it could be 
speculated that the effects of ADPN represent a peripheral 
satiety signal that might contribute to the anorexigenic 
effects of the hormone[4,27]. In this view, the importance 
of the gastrointestinal tract in controlling food intake is 
well recognized[28] and the ability of signals generated in 
this apparatus to influence food intake through the vagal 
afferent fibers is well established[29,30]. In this regard, 
the presence of ADPN receptors in both mucosal and 
muscular vagal afferents in the gastric antrum of mice 
has been reported[8], suggesting a stomach­vagal­brain 
pathway for ADPN to modulate satiety signals. Thus, the 
observed effects of ADPN on gastric motor responses 
might be regarded as a reinforcing peripheral mechanism 
engaged by ADPN to regulate food intake.  
In conclusion, the present study demonstrates for 
the first time that ADPN, likely involving the NO pathway, 
is able to affect the mechanical responses in strips from 
the mouse gastric fundus. This may furnish the basis to 
better explore the link between the peripheral and the 
central effects of ADPN in sending satiety signals and, 
thus, in the regulation of food intake[31]. Interestingly, 
clinical evidence of an increased NO production in pa­
tients affected by eating disorders, such as anorexia 
nervosa and bulimia nervosa, has been reported[32]. 
Thus, even if caution is needed when transferring data 
obtained in animal to human, the present results might 
represent a contribution to consider ADPN as a potential 
candidate for both novel therapeutic strategies in eating 
disorders and diagnostic tools.  
ARTICLE HIGHLIGHTS
Research background
The adipose-tissue derived hormone adiponectin (ADPN) has been reported 
to have a role as a key neuromodulator of food intake. It is known that 
gastrointestinal motor phenomena represent a source of peripheral signals 
involved in the control of feeding behavior. However, no data are available 
concerning on the effects of ADPN on gastrointestinal motility. This novel 
information could highlight an additional mechanism engaged by the hormone 
in the control of food intake.  
Research motivation
The finding that ADPN could influence gastric motility might represent an 
initial step to regard the peripheral effects of the hormone as possible signals 
involved in the control of food intake. This aspect, that certainly deserves to be 
deeper investigated, could lead to consider ADPN as a potential candidate for 
both novel therapeutic strategies in eating disorders and diagnostic tools. 
Research objectives
The main objective of the present study was to investigate the influence of 
ADPN on the mechanical responses and the expression of its receptors in the 
mouse gastric fundus.
Research methods
For the mechanical experiments, longitudinal muscle strips from the mouse 
gastric fundus were connected to force displacement transducers for continuous 
recording of isometric tension. The expression of ADPN receptors in gastric 
fundal tissue was revealed by touchdown- polymerase chain reaction (PCR) 
analysis. 
Research results
The present results highlight that, in the mouse gastric strips, ADPN induces 
inhibitory effects by decreasing the amplitude of the neurally-induced contractile 
responses, enhancing that of the relaxant ones and causing a decay of the 
basal tension. Some of these actions appear to be mediated, at least in part, by 
nitric oxide although further studies are needed to better clarify the mechanism 
through which the hormone exerts its effects.
Research conclusions
The results of the present study indicate for the first time that ADPN is able 
to exert inhibitory effects on the mechanical responses of the mouse gastric 
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fundus in which we revealed the expression of ADPN receptors. It could be 
hypothesized that the hormone effects may be directed to facilitate muscle 
relaxation, so increasing the distension of the gastric wall that represents a 
peripheral satiety signal. In this view, the results of the present study may 
furnish the basis to better explore the link between peripheral and central 
effects of ADPN in the regulation of food intake.  
Research perspectives
The results of the present basic research might furnish a contribution to 
consider ADPN as a potential candidate for both novel therapeutic strategies in 
eating disorders and diagnostic tools. 
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